Vitamin D supplementation during pregnancy and infancy reduces aeroallergen sensitization: a randomized controlled trial

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 71, Issue 9, 2016, Pages 1325-1334

  Grant, C C ^a,b   Crane, J ^c   Mitchell, E A ^a   Sinclair, J ^b   Stewart, A ^a   Milne, T ^a   Knight, J ^a   Gilchrist, C ^a   Camargo, C A ^d  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

asthma; infant; pregnancy; supplementation; Vitamin D, 25 hydroxyvitamin D

Indexed keywords

DER F1 ALLERGEN; DER F2 ALLERGEN; DER P1 ALLERGEN; DER P2 ALLERGEN; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; PLACEBO; PREDNISONE; SALBUTAMOL; UNCLASSIFIED DRUG; VITAMIN D; ALLERGEN;

ARTICLE; ASTHMA; BIRTH; BRONCHIOLITIS; BRONCHITIS; CAT; CHILD; COLD; CONTROLLED STUDY; COUGHING; CROUP; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; FEVER; FOLLOW UP; GRASS POLLEN; HOUSE DUST ALLERGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFANCY; INFANT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; OTITIS MEDIA; OUTCOME ASSESSMENT; PARALLEL DESIGN; POLLEN ALLERGY; PREGNANCY; PREGNANT WOMAN; PRESCHOOL CHILD; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFECTION; THIRD TRIMESTER PREGNANCY; UPPER RESPIRATORY TRACT INFECTION; VITAMIN SUPPLEMENTATION; WHEEZING; BLOOD; CLINICAL TRIAL; COMORBIDITY; DIETARY SUPPLEMENT; HYPERSENSITIVITY; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGY; MALE; MATERNAL EXPOSURE; NEWBORN; PRENATAL EXPOSURE; SKIN TEST;

ALLERGENS; COMORBIDITY; DIETARY SUPPLEMENTS; FEMALE; HUMANS; HYPERSENSITIVITY; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; INFANT; INFANT, NEWBORN; MALE; MATERNAL EXPOSURE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SKIN TESTS; VITAMIN D;

EID: 84973124559     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12909     Document Type: Article

References (48)

1. Holloway JW, Holgate ST. Genetics. In: Johannsson SGO, Haahtela T. editors. Prevention of Allergy and Allergic Asthma: World Allergy Organization Project Report and Guidelines. Basel: KARGER; 2004: 1–35.
2. Warner JO. The early life origins of asthma and related allergic disorders. Arch Dis Child 2004;89:97–102.
3. Holt PG, Upham JW, Sly PD. Contemporaneous maturation of immunologic and respiratory functions during early childhood: implications for development of asthma prevention strategies. J Allergy Clin Immunol 2005;116:16–24.
4. Grammatikos AP. The genetic and environmental basis of atopic diseases. Ann Med 2008;40:482–495.
5. Adorini L, Penna G. Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. Hum Immunol 2009;70:345–352.
6. Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr 1995;125 (Suppl.):1704S–1708S.
7. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol 2010;10:482–496.
8. Chambers ES, Hawrylowicz CM. The impact of vitamin D on regulatory T cells. Curr Allergy Asthma Rep 2011;11:29–36.
9. Hypponen E, Berry DJ, Wjst M, Power C. Serum 25-hydroxyvitamin D and IgE - a significant but nonlinear relationship. Allergy 2009;64:613–620.
10. Rothers J, Wright AL, Stern DA, Halonen M, Camargo CA Jr. Cord blood 25-hydroxyvitamin D levels are associated with aeroallergen sensitization in children from Tucson, Arizona. J Allergy Clin Immunol 2011;128:1093–1099.
11. Grant CC, Stewart AW, Scragg R, Milne T, Rowden J, Ekeroma A et al. Vitamin D during pregnancy and infancy and infant serum 25-hydroxyvitamin D concentration. Pediatrics 2014;133:e143–e153.
12. Ministry of Health and Cancer Society of New Zealand. Consensus Statement on Vitamin D and Sun Exposure in New Zealand. Wellington: Ministry of Health; 2012.
13. Ministry of Health. Companion Statement on Vitamin D and Sun Exposure in Pregnancy and Infancy in New Zealand. Wellington: Ministry of Health; 2013.
14. Camargo CA Jr, Ingham T, Wickens K, Thadhani RI, Silvers KM, Epton MJ et al. Vitamin D status of newborns in New Zealand. Br J Nutr 2010;104:1051–1057.
15. Asher MI, Barry D, Clayton T, Crane J, D'Souza W, Ellwood P et al. The burden of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema in children and adolescents in six New Zealand centres: ISAAC Phase One. N Z Med J 2001;114:114–120.
16. Weinmayr G, Weiland SK, Bjorksten B, Brunekreef B, Buchele G, Cookson WO et al. Atopic sensitization and the international variation of asthma symptom prevalence in children. Am J Respir Crit Care Med 2007;176:565–574.
17. Grant CC, Kaur S, Waymouth E, Mitchell EA, Scragg R, Ekeroma A et al. Reduced primary care respiratory infection visits following pregnancy and infancy vitamin D supplementation: a randomised controlled trial. Acta Paediatr 2015;104:396–404.
18. Ekeroma AJ, Camargo CAJ, Scragg R, Wall C, Stewart A, Mitchell E et al. Predictors of vitamin D status in pregnant women in New Zealand. N Z Med J 2015;128:24–34.
19. ASCIA Skin Prick Testing Working Party. Skin prick testing for the diagnosis of allergic disease: a manual for practitioners. Brookvale NSW: Australasian Society of Clinical Immunology and Allergy Inc; 2006.
20. Johansson SG. ImmunoCAP Specific IgE test: an objective tool for research and routine allergy diagnosis. Expert Rev Mol Diagn 2004;4:273–279.
21. Bernstein IL, Li JT, Bernstein DI, Hamilton R, Spector SL, Tan R et al. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol 2008;100 (Suppl. 3):S1–S148.
22. Warner JA, Jones CA, Jones AC, Warner JO. Prenatal origins of allergic disease. J Allergy Clin Immunol 2000;105:S493–S498.
23. Jones AC, Miles EA, Warner JO, Colwell BM, Bryant TN, Warner JA. Fetal peripheral blood mononuclear cell proliferative responses to mitogenic and allergenic stimuli during gestation. Pediatr Allergy Immunol 1996;7:109–116.
24. Manaseki-Holland S, Maroof Z, Bruce J, Mughal MZ, Masher MI, Bhutta ZA et al. Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial. Lancet 2012;379:1419–1427.
25. Martineau AR. Bolus-dose vitamin D and prevention of childhood pneumonia. Lancet 2012;379:1373–1375.
26. Hansell A, Hollowell J, Nichols T, McNiece R, Strachan D. Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4). Thorax 1999;54:413–419.
27. Mansbach JM, Espinola JA, Macias CG, Ruhlen ME, Sullivan AF, Camargo CA Jr. Variability in the diagnostic labeling of nonbacterial lower respiratory tract infections: a multicenter study of children who presented to the emergency department. Pediatrics 2009;123:e573–e581.
28. Pojsupap S, Iliriani K, Sampaio TZ, O'Hearn K, Kovesi T, Menon K et al. Efficacy of high-dose vitamin D in pediatric asthma: a systematic review and meta-analysis. J Asthma 2015;52:382–390.
29. Schou AJ, Heuck C, Wolthers OD. Does vitamin D administered to children with asthma treated with inhaled glucocorticoids affect short-term growth or bone turnover? Pediatr Pulmonol 2003;36:399–404.
30. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010;91:1255–1260.
31. Majak P, Olszowiec-Chlebna M, Smejda K, Stelmach I. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. J Allergy Clin Immunol 2011;127:1294–1296.
32. Lewis E, Fernandez C, Nella A, Hopp R, Gallagher JC, Casale TB. Relationship of 25-hydroxyvitamin D and asthma control in children. Ann Allergy Asthma Immunol 2012;108:281–282.
33. Yadav M, Mittal K. Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian J Pediatr 2014;81:650–654.
34. Arshi S, Fallahpour M, Nabavi M, Bemanian MH, Javad-Mousavi SA, Nojomi M et al. The effects of vitamin D supplementation on airway functions in mild to moderate persistent asthma. Ann Allergy Asthma Immunol 2014;113:404–409.
35. Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine–reporting of subgroup analyses in clinical trials. N Engl J Med 2007;357:2189–2194.
36. Goldhahn K, Bockelbrink A, Nocon M, Almqvist C, DunnGalvin A, Willich SN et al. Sex-specific differences in allergic sensitization to house dust mites: a meta-analysis. Ann Allergy Asthma Immunol 2009;102:487–494.
37. Sears MR, Burrows B, Flannery EM, Herbison GP, Holdaway MD. Atopy in childhood. I. Gender and allergen related risks for development of hay fever and asthma. Clin Exp Allergy 1993;23:941–948.
38. Bousquet PJ, Chinn S, Janson C, Kogevinas M, Burney P, Jarvis D et al. Geographical variation in the prevalence of positive skin tests to environmental aeroallergens in the European Community Respiratory Health Survey I. Allergy 2007;62:301–309.
39. Kidon MI, Chiang WC, Liew WK, Lim SH, See Y, Goh A et al. Sensitization to dust mites in children with allergic rhinitis in Singapore: does it matter if you scratch while you sneeze? Clin Exp Allergy 2005;35:434–440.
40. Wickens K, Siebers R, Ellis I, Lewis S, Sawyer G, Tohill S et al. Determinants of house dust mite allergen in homes in Wellington, New Zealand. Clin Exp Allergy 1997;27:1077–1085.
41. Lau S, Illi S, Sommerfeld C, Niggemann B, Bergmann R, von Mutius E et al. Early exposure to house-dust mite and cat allergens and development of childhood asthma: a cohort study, Multicentre Allergy Study Group. Lancet 2000;356:1392–1397.
42. Sporik R, Holgate ST, Platts-Mills TA, Cogswell JJ. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med 1990;323:502–507.
43. McGlade JP, Gorman S, Zosky GR, Larcombe AN, Sly PD, Finlay-Jones JJ et al. Suppression of the asthmatic phenotype by ultraviolet B-induced, antigen-specific regulatory cells. Clin Exp Allergy 2007;37:1267–1276.
44. Rhodes HL, Thomas P, Sporik R, Holgate ST, Cogswell JJ. A birth cohort study of subjects at risk of atopy: twenty-two-year follow-up of wheeze and atopic status. Am J Respir Crit Care Med 2002;165:176–180.
45. Weisse K, Winkler S, Hirche F, Herberth G, Hinz D, Bauer M et al. Maternal and newborn vitamin D status and its impact on food allergy development in the German LINA cohort study. Allergy 2013;68:220–228.
46. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995;332:133–138.
47. Rasmussen F, Taylor DR, Flannery EM, Cowan JO, Greene JM, Herbison GP et al. Risk factors for hospital admission for asthma from childhood to young adulthood: a longitudinal population study. J Allergy Clin Immunol 2002;110:220–227.
48. Beasley R, Semprini A, Mitchell EA. Risk factors for asthma: is prevention possible? Lancet 2015;386:1075–1085.